湖南中医药大学学报2024，Vol.44Issue(7)：1328-1334,7.DOI:10.3969/j.issn.1674-070X.2024.07.028
青光眼滤过术后抗瘢痕化的研究进展
Research progress on anti-scarring after glaucoma filtration surgery
摘要
Abstract
The typical manifestation of glaucoma is characterized by a pathological increase in intraocular pressure,and surgical treatment serves as a means of rapidly reducing it.The success rate of glaucoma filtration surgery is closely linked to postoperative anti-scarring,making anti-scarring an important factor in enhancing the success rate of glaucoma surgery.In addition to traditional anti-metabolic drugs,there are also novel anti-metabolic drugs,new molecular biomaterials,genetic materials,etc.At the same time,Chinese medicine has also delved into the study of anti-scar drugs.This paper reviews the recent research on anti-scarring for glaucoma filtration surgery.关键词
青光眼/抗瘢痕化/青光眼滤过手术/成纤维细胞/抗血管内皮生长因子药物/中药Key words
glaucoma/anti-scarring/glaucoma filtration surgery/fibroblast/anti-vascular endothelial growth factor drugs/Chinese medicines分类
医药卫生引用本文复制引用
周小钰,李方芳,刘倩宏,姚小磊..青光眼滤过术后抗瘢痕化的研究进展[J].湖南中医药大学学报,2024,44(7):1328-1334,7.基金项目
湖南省"芙蓉学者"奖励计划(湘人才办[2022]3号) （湘人才办[2022]3号）
湖南中医药大学"王衡新科研基金"项目(2023HX007) （2023HX007）
湖南省研究生科研创新项目(2023CX45) （2023CX45）
湖南省卫生健康委员会高层次人才计划(2022年). （2022年）
